Tamuzimod (VTX002) is an orally active sphingosine-1-phosphate receptor 1 (S1PR1) modulator. By binding to and modulating S1PR1 expressed on the surface of activated lymphocytes, Tamuzimod mediates lymphocyte egress from lymphoid organs, thereby retaining lymphocytes in peripheral lymphoid tissues and reducing circulating lymphocyte counts. Tamuzimod can be used in research related to moderate-to-severe ulcerative colitis[1][2].
Molecular Weight:
546.71
CAS Number:
[2097854-81-2]
Formula:
C21H13Cl3F3N5O3
Target:
LPL Receptor
Application Notes:
MCE Product type: Reference compound1
* VAT and and shipping costs not included. Errors and price changes excepted
